Rodolfo Delfini Cancado

6PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyMajor global burdens of diseaseNutritional epidemiologyCell and nuclear division
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 17, 2026
A Multicenter, Open-Label, Phase 2 Trial Comparing Crizanlizumab Combined With Standard Therapy to Standard Therapy Alone on Renal Function in Patients With Sickle Cell Nephropathy (STEADFAST).

|Jul 16, 2026
Beyond Hemoglobin: The Clinical Imperative for Managing Nonanemic Iron Deficiency in Perioperative Care-A Perspective.

|Feb 13, 2025
Defining Global Thresholds for Serum Ferritin: A Challenging Mission in Establishing the Iron Deficiency Diagnosis in This Era of Striving for Health Equity.

Rodolfo Delfini Cancado, Lauro Augusto Caetano Leite, Manuel Muñoz

|Aug 09, 2023
Iron deficiency anemia in women: pathophysiological, diagnosis, and practical management.

Rodolfo Delfini Cançado

|Apr 27, 2023
Estimated mortality rates of individuals with sickle cell disease in Brazil: real-world evidence.

Rodolfo Delfini Cançado, Fernando Ferreira Costa, Clarisse Lobo

|Oct 26, 2022
Brazilian family with hyperferritinemia-cataract syndrome: case report.

Aline Morgan Alvarenga, Nathália Kozikas da Silva, Rodolfo Delfini Cançado

Pageof 1

Frequent Collaborators

1 joint publications

Ioav Cabantchik

1 joint publications

Domenico Girelli

1 joint publications

Vernon Louw

1 joint publications

Patrick Meybohm